Tobrasone®

Ophthalmic Solution

Antibiotic Association - Specific Anti-inflammatory for Eye Processes
Canines Horses Felines

Formulation

Each mL contains Tobramycin Sulfate (eq. To Tobramycin) 3 mg, Dexamethasone Sodium Phosphate (eq. To Dexamethasone Phosphate) 1 mg, excipients c.s.p. 1 mL

Indications

Treatment and prevention of external infections of the eye and ocular annexes caused by germs susceptible to tobramycin and when an anti-inflammatory effect is also required. Blepharitis, conjunctivitis and/or bacterial keratoconjunctivitis, corneal infection by Staphylococcus aureus, as well as an adjunct in the treatment of severe intraocular infections (including those caused by Pseudomona aueroginosa). Inflammation of the palpebral conjunctiva, bulbar conjunctiva, cornea and anterior segment of the eye, when accompanied by bacterial inflammation or the risk of developing such inflammation. Corneal abrasions and superficial traumatic lesions of the eyeball. Contaminated dry keratitis and corneal ulcer caused by susceptible microorganisms, lesions and/or infections in the anterior chamber of the eye. Pre- and post-surgical prophylaxis of the eye. Control of posttraumatic ocular inflammation, as well as reduction in the risk of infection.

Dosage and Administration

Topical ophthalmic route. In moderate ophthalmic infections: 1-2 drops every 4-6 hours for at least 5 days. In severe ophthalmic infections: 2 drops every 1-4 hours for at least 7 days

Commercial Presentation

Dropper Bottle x 10 mL,

SENASA Registry